Medically reviewed
Best Peptides for Anti-Aging and Longevity in 2026
Overview
Anti-aging peptides target several hallmarks of aging: skin degradation, telomere shortening, mitochondrial dysfunction, hormonal decline, and metabolic slowdown. This guide compares peptides with the most relevant research for longevity and age-related health.
Quick Comparison
| Peptide | Evidence Grade | Primary Mechanism | Anti-Aging Focus |
|---|---|---|---|
| GHK-Cu | Moderate | Copper signalling, gene expression | Skin, collagen, wound healing |
| Epitalon | Preliminary | Telomerase activation | Telomere length, pineal function |
| SS-31 | Moderate | Cardiolipin stabilisation | Mitochondrial function |
| CJC-1295 | Preliminary | Growth hormone release | Hormonal optimisation |
| MOTS-c | Preliminary | AMPK activation | Metabolic health, exercise mimetic |
Individual Peptide Breakdown
GHK-Cu — Skin and Gene Expression
GHK-Cu is the most accessible anti-aging peptide, available over-the-counter in topical formulations worldwide. Research demonstrates that GHK-Cu declines significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. Studies suggest it may reset the expression of over 4,000 genes toward a healthier pattern, with particular relevance to collagen synthesis, skin elasticity, and wound healing. Comparative studies have shown topical GHK-Cu performing on par with tretinoin for skin rejuvenation.
Epitalon — Telomere Research
Epitalon is a synthetic version of epithalamin, a peptide naturally produced by the pineal gland. Research by Prof. Vladimir Khavinson spanning over 30 years suggests that Epitalon may activate telomerase — the enzyme responsible for maintaining telomere length. Telomere shortening is a key biomarker of cellular aging. Animal studies have reported increased telomere length and extended lifespan in treated subjects, though human data remains limited.
SS-31 (Elamipretide) — Mitochondrial Health
SS-31 uniquely targets the inner mitochondrial membrane, binding to cardiolipin to stabilise electron transport chain function. Mitochondrial dysfunction is considered a primary driver of aging. SS-31 has the most robust clinical trial programme of any peptide on this list, with Phase 2/3 trials in Barth syndrome, heart failure, and mitochondrial myopathy. It is the closest to potential FDA approval.
CJC-1295 — Growth Hormone Optimisation
Growth hormone levels decline approximately 14% per decade after age 30. CJC-1295 stimulates natural GH production, and when combined with Ipamorelin, may help restore more youthful GH levels. Adequate growth hormone supports body composition, skin quality, bone density, and energy levels — all relevant to aging.
MOTS-c — The Exercise Mimetic
MOTS-c is a mitochondria-derived peptide that activates AMPK — the same pathway activated by exercise and caloric restriction. Research suggests it may improve insulin sensitivity, enhance fat metabolism, and improve exercise performance. As a relatively recently discovered peptide (2015), its anti-aging potential is still being defined, but its metabolic effects are directly relevant to healthspan.
Stacking Considerations
Common anti-aging peptide combinations include:
- GHK-Cu (topical) + Epitalon — skin health plus telomere support
- SS-31 + MOTS-c — mitochondrial function plus metabolic health
- CJC-1295 + Ipamorelin + GHK-Cu — hormonal optimisation plus skin
All stacking should be supervised by a qualified healthcare provider.
Important Considerations
- Anti-aging research is an active and evolving field — evidence varies significantly by peptide
- GHK-Cu topical is legal and available OTC; other peptides require prescriptions or exist in regulatory grey areas
- Longevity claims should be viewed with appropriate scepticism — most data is preclinical
- Blood work monitoring is essential for GH-releasing peptides
- Lifestyle fundamentals (sleep, exercise, nutrition) remain the foundation of longevity
How We Evaluate
Our comparisons are based on published research, clinical trial data, and our evidence grading system. See our editorial policy.